Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Toyoshima Satoshi is active.

Publication


Featured researches published by Toyoshima Satoshi.


Molecular Immunology | 1982

Lectin-induced mitosis and phospholipid methylation☆

Toyoshima Satoshi; Hirata Fusao; Iwata Makoto; Julius Axelrod; Osawa Toshiaki; M.J. Waxdal

The binding of the mitogenic lectins concanavalin A, Wistaria floribunda mitogen, Pisum sativum hemagglutinin, Lens culinaris lectin, phytohemagglutinin, and two of the pokeweed mitogens (Pa-1 and Pa-2), in mitogenic concentrations to the cell surface acceptors of murine splenic lymphocytes caused a rapid, transient increase in the methylation of lymphocyte phospholipid. The extent of this increase was dependent upon the concentration of the lectin, and paralleled the dose-response curve for subsequent mitosis. Higher or lower doses of lectin did not cause the observed changes in methylation nor induce mitosis. The increase of phospholipid methylation reached a maximum about 10 min after the addition of the mitogenic lectins and then decreased to control levels within about 45 min. Accordingly, mitogenic lectins not only stimulate phospholipid methylation in lymphocytes, but also stimulate degradation of the phospholipids, probably by phospholipase A2. The non-mitogenic lectins, Sophora japonica hemagglutinins (Sj-I and Sj-II), W. floribunda hemagglutinin, and Bauhinea purpurea hemagglutinin did not significantly affect the phospholipid methylation. Preincubation of lymphocytes for 1 hr with 10−5M of the methylation inhibitor. S-isobutyryl-3-deazaadenosine, suppressed both the concanavalin A (Con A)-induced increase of phospholipid methylation after 10 min, and subsequent DNA synthesis after 45 hr. This concentration of methylation inhibidid not affect these responses if added immediately after the Con A stimulation, and appears to be specific for the phospholipid methylation. The degradation of methylated phospholipid was blocked by the phospholipase A2 inhibitor, mepacrine, which also suppressed DNA synthesis. The T-cell mitogen, Con A. showed the same lymphocyte specificity for phospholipid methylation enhancement as for stimulation of DNA synthesis. Con A caused the transient increase of phospholipid methylation in murine thymocytes, spleen cells treated with anti-immunoglobulin and complement, and purified T-cells. On the other hand, Con A did not cause a meaningful change of phospholipid methylation in spleen lymphocytes from athymic nude mice, spleen cells treated with rabbit anti-mouse brain and complement, or purified B-cells. From these results, it appears that both increased phospholipid methylation and degradation in mitogen-stimulated lymphocytes may be an integral part of the mitogenic signal.


Molecular Immunology | 1992

Purification and cDNA cloning of a novel factor produced by a human T-cell hybridoma: sequence homology with animal lectins.

Yoshimatsu Kentaro; Ohya Yukio; Shikata Yasushi; Seto Toshio; Hasegawa Yoshikazu; Tanaka Isao; Kawamura Tamio; Kitoh Kyousuke; Toyoshima Satoshi; Osawa Toshiaki

We have purified a novel immunoregulatory factor (BMPG: bone-marrow proteoglycan) produced by a T-cell hybridoma, with a monoclonal antibody column. Using an oligonucleotide probe corresponding to the partial amino acid sequence of BMPG, we cloned, sequenced, and expressed a cDNA for BMPG. BMPG has 222 amino acid residues with a 16 N-terminal signal sequence, so the mature form has 206 amino acid residues. BMPG was found to have unique characteristics: it has three types of sugar chains and it shows a marked homology with animal lectins including the human asialoglycoprotein receptor, chicken hepatic lectin and the homing receptor of lymphocytes.


Archive | 1983

N-Acetylneuraminic acid derivatives and process for the preparation thereof

Ogura Haruo; Furuhata Kimio; Osawa Toshiaki; Toyoshima Satoshi; Shitori Yoshiyasu; Ito Masayoshi


Archive | 1982

DERIVES DE L'ACIDE N-ACETYLNEURAMINIQUE ET LEUR PREPARATION

Ogura Haruo; Furuhata Kimio; Osawa Toshiaki; Toyoshima Satoshi; Shitori Yoshiyasu; Ito Masayoshi


Archive | 1985

SIALIC ACID DERIVATIVE AND ITS PREPARATION

Ogura Haruo; Furuhata Kimio; Oosawa Toshiaki; Toyoshima Satoshi; Shidori Yoshiyasu; Itou Masayoshi; Yoshimura Shiyouji


Archive | 1985

DERIVES D'ACIDE SIALIQUE, LEURS PROCEDES DE PREPARATION ET LEURS APPLICATIONS NOTAMMENT COMME MEDICAMENT INHIBITEUR DE LA METASTASE DES CELLULES CANCEREUSES

Ogura Haruo; Furuhata Kimio; Osawa Toshiaki; Toyoshima Satoshi; Shitori Yoshiyasu; Ito Masayoshi; Yoshimura Shoji


Archive | 1984

Inhibitor against cancer metastasis

Suda Isao; Toyoshima Satoshi; Osawa Toshiaki; Ito Masayoshi; Shidori Yoshiyasu


Archive | 1983

CONJUGATED GLYCOSIDE DERIVATIVE

Ogura Haruo; Furuhata Kimio; Oosawa Toshiaki; Toyoshima Satoshi; Shidori Yoshiyasu; Itou Masayoshi; Kijima Isao


Archive | 1982

N-ACETYLNEURAMINSAEURE-DERIVATE

Ogura Haruo; Furuhata Kimio; Osawa Toshiaki; Toyoshima Satoshi; Shitori Yoshiyasu; Ito Masayoshi


Archive | 1990

NEUTRAL SACCHARIDE-CONTAINING LUTEINIZED HORMONE AND USE THEREOF

Omura Kazutaka; Nakamura Yasunori; Nomura Kaoru; Ujihara Makoto; Toyoshima Satoshi; Yamamoto Kazuo; Osawa Toshiaki; Shizume Kazuo

Collaboration


Dive into the Toyoshima Satoshi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Julius Axelrod

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

M.J. Waxdal

National Institutes of Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge